Modelling the interaction between human immunodeficiency virus, mycobacterium tuberculosis and the human immune system, including the effects of drug therapy.
Tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV) in several African countries, including South Africa. HIV-positive individuals do not have the immune system resources to keep TB in check and are as much as 30 times more likely to develo...
Main Author: | Ramkissoon, Santosh. |
---|---|
Other Authors: | Matthews, A. P. |
Language: | en |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10413/1056 |
Similar Items
-
The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01) -
Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape
Published: (2018) -
Postantibiotic effects of anti-tuberculosis drugs on mycobacterium tuberculosis.
Published: (1997) -
Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan
by: Takashi Matsumoto, et al.
Published: (2018-12-01) -
Aerosol pentamidine for prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus infected individuals
by: McIvor, Robert Andrew
Published: (1994)